| Similar Articles |
|---|
 |
Fast Company
November 2002
Keith H. Hammonds |
Harry Kraemer's Moment of Truth In an era when the business section read like the police blotter, the CEO of medical products and pharmaceutical company Baxter International faced a tough ethical dilemma. And he did something noteworthy: He actually did the right thing.   |
HBS Working Knowledge
September 29, 2003
Michael Sisk |
Do the Right Thing How does a commitment to "do the right thing" as it's applied to customers, employees, and other stakeholders affect an organization's daily decision making? |
Chemistry World
December 6, 2012
Andrew Turley |
Baxter to pay $4bn for dialysis firm US drug maker Baxter has struck a deal to buy privately-owned Swedish firm Gambro, which makes dialysis products, for $4 billion |
The Motley Fool
April 10, 2008
Brian Orelli |
The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company. |
The Motley Fool
April 18, 2008
Brian Orelli |
Recalls Can't Beat Baxter In spite of charges for two recalls, Baxter posts a decent quarter. |
Chemistry World
March 28, 2014
Phillip Broadwith |
Baxter aims to divide and conquer US drugmaker Baxter International is spinning off its biopharmaceuticals business to create two independent companies. |
The Motley Fool
July 20, 2007
Brian Orelli |
Baxter's Mixed Message A recall of Baxter BioScience's COLLEAGUE infusion pumps seems to have over-shadowed healthy quarterly earnings reports. |
The Motley Fool
January 23, 2009
Robert Steyer |
BAX to the Future After minding its own business, Baxter International starts thinking about acquisitions again. |
The Motley Fool
January 28, 2005
Brian Gorman |
Baxter Plods On 2005 looks like another year of transition for Baxter International. The medical products and services concern reported that after currency adjustments, fourth-quarter 2004 revenue of $2.6 billion was essentially flat compared with the same period in 2003. |
The Motley Fool
November 3, 2011
Dan Caplinger |
Has Baxter International Become the Perfect Stock? Baxter needs to keep working on getting its debt levels down and seek out new growth opportunities. With favorable demographic winds at its back, Baxter could be the rare stock to actually reach perfection. |
The Motley Fool
April 17, 2009
Robert Steyer |
The Steady BAX Beat Baxter International's diverse medical offerings continue to produce prosperity. |
Registered Rep.
June 14, 2007
Kevin Burke |
Pilgrim Baxter's Payback The SEC announced this week that it is returning ill-gotten gains to Pilgrim Baxter (investment advisor to the PBHG fund family) shareholders, three and half years after the fund company was engulfed in a trading scandal. |
The Motley Fool
April 22, 2005
Brian Gorman |
Baxter Is on the Mend The medical products company continues to right itself for a brighter future. The firm's long-term positioning and diversified business may make it worth a closer look. |
The Motley Fool
December 23, 2003
Jeff Hwang |
Bad, Bad Baxter The medical products company issues its latest in a series of earnings warnings. |
AskMen.com
James Matheson |
Baxter of California Grooming Products Sure, men spend money on expensive shaving creams and fancy razors, but that's not the only way a man can take care of his face. |
Insurance & Technology
August 19, 2010
Katherine Burger |
ING Insurance U.S. Names New CIO Gary Baxter - previously from head of IT, ING U.S. Retirement Services, ING Individual Retirement, and company's closed block of business - will oversee technology investments and IT operations across all U.S. business lines. |
The Motley Fool
October 16, 2009
Robert Steyer |
Baxter Beats Again -- the Streak Is Alive! The drug, device, and medical services giant beats Wall Street earnings estimates by a penny, but flat sales signal caution. |
The Motley Fool
October 19, 2007
Brian Orelli |
Baxter Gets Pumped Up Medical-device maker Baxter puts in a nice quarter despite two recent FDA recalls. |
The Motley Fool
February 29, 2008
Brian Orelli |
Bigger Recall, No Big Deal Baxter increases its recall of heparin, but investors shouldn't be that worried. |
CIO
October 28, 2011
Kim S. Nash |
Why Legal Concerns Put a Halt to BYOT at Baxter Baxter International wanted to allow employees to bring their own devices to work, but legal concerns related to e-discovery had to be resolved first. |
Insurance & Technology
September 5, 2006
Maria Woehr |
Thrilling Service To maintain its dominant position in Maine's worker's compensation market, Maine Employer's Mutual Insurance Company leverages IT to improve service for its agent customers. |
